Retention Agreements in the Pharmaceuticals Industry

77 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated 2024 Form of Executive Retention Agreement
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Retention Agreement, by and between the Canopy Growth Corporation and Christelle Gedeon, effective as of August 19, 2024
Retention Agreements
Canopy Growth Corp
Pharmaceuticals
2024
Retention Agreement, by and between the Canopy Growth Corporation USA, LLC and Judy Hong, effective as of August 19, 2024
Retention Agreements
Canopy Growth Corp
Pharmaceuticals
2024
Retention Award Agreement, dated July 1, 2024, by and between the Registrant and Jotin Marango, M.D., Ph.D
Retention Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
Retention Award Agreement, dated July 1, 2024, by and between the Registrant and Mark Manfredi, Ph.D
Retention Agreements
Ikena Oncology, Inc.
Pharmaceuticals
2024
2024 Form of Executive Retention Agreement
Retention Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Form Retention Agreement
Retention Agreements
Catalent Inc
Pharmaceuticals
DE
2024
Form of Executive Retention Agreement
Retention Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2024
Form of Retention Letter
Retention Agreements
Mallinckrodt
Pharmaceuticals
2023
Form of Award Notice under PLx Pharma Inc. 2023 Key Executive Retention Plan
Retention Agreements
PLx Pharma Inc.
Pharmaceuticals
2023
PLx Pharma Inc. 2023 Key Executive Retention Plan
Retention Agreements
PLx Pharma Inc.
Pharmaceuticals
NY
2023
Retention Agreement between Endo and Patrick Barry, dated August 11, 2022
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Matthew J. Maletta, dated August 11, 2022
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Mark T. Bradley, dated August 11, 2022
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Blaise Coleman, dated August 11, 2022
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Amendment to Amended and Restated Retention Agreement, dated as of May 18, 2022, by and between the Company and Michael P. Gray
Retention Agreements
IMARA Inc.
Pharmaceuticals
2022
Amendment to Retention Agreement, dated as of May 5, 2022, by and between the Company and Rahul D. Ballal, Ph.D
Retention Agreements
IMARA Inc.
Pharmaceuticals
2022
Form of Retention Award Letter
Retention Agreements
Lannett Company, Inc.
Pharmaceuticals
PA
2022
Amended and Restated Retention Agreement, dated as of May 18, 2022, by and between the Registrant and Michael P. Gray
Retention Agreements
IMARA Inc.
Pharmaceuticals
2022
February 18, 2022 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2022
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Michael P. Gray
Retention Agreements
IMARA Inc.
Pharmaceuticals
2022
Retention Agreement, dated as of May 5, 2022, by and between the Registrant and Rahul D. Ballal, Ph.D
Retention Agreements
IMARA Inc.
Pharmaceuticals
2022
Retention Agreement, dated March 7, 2022, between Michael F. Marino and Optinose US, Inc
Retention Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2022
Retention Agreement between Endo and Patrick Barry, dated November 1, 2021
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Matthew J. Maletta, dated November 1, 2021
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Mark T. Bradley, dated November 1, 2021
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Retention Agreement between Endo and Blaise Coleman, dated November 1, 2021
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Form of Retention Agreement
Retention Agreements
Cara Therapeutics, Inc.
Pharmaceuticals
2022
Tricida, Inc. Executive Retention Agreement Template Amendment
Retention Agreements
Tricida, Inc.
Pharmaceuticals
2021
June 21, 2019 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2021
Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Anthony Mauro
Retention Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Retention Agreement entered into on December 3, 2020, by and between Viatris Inc. and Rajiv Malik
Retention Agreements
Upjohn Inc
Pharmaceuticals
PA
2021
Retention Agreements by and between Tilray and each of Michael Kruteck and Jon Levin dated December 18, 2020
Retention Agreements
Tilray, Inc.
Pharmaceuticals
2020
Retention agreement, dated October 29, 2020 between Acasti Pharma Inc. and Pierre Lemieux
Retention Agreements
Acasti Pharma Inc.
Pharmaceuticals
2020
Retention agreement, dated October 27, 2020, between Acasti Pharma Inc. and Jan DAlvise
Retention Agreements
Acasti Pharma Inc.
Pharmaceuticals
2020
Tricida, Inc. Executive Retention Agreement Template
Retention Agreements
Tricida, Inc.
Pharmaceuticals
2020
Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
Retention Agreements
Nabriva Therapeutics plc
Pharmaceuticals
PA
2020
EXECUTIVE RETENTION AGREEMENT
Retention Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
MD
2020
June 21, 2019 Retention Agreement with Douglas Plassche
Retention Agreements
ELITE PHARMACEUTICALS INC
Pharmaceuticals
2020
Key Employee Retention Plan
Retention Agreements
Sienna Biopharmaceuticals, Inc.
Pharmaceuticals
CA
2019